Skip to main content
    B

    Bausch Health Companies Inc (BHC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $8.48
    +0.06 (+0.71%)

    Market Cap: $3.15B

    Last updated: Nov 17, 2026 at 4:17 PM ET

    Bausch Health Companies Inc (BHC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Bausch Health Companies (BHC) has a market cap of $3.15B and an enterprise value of $21.30B. Its net debt of $18.15B equals 576.01% of its market cap. Its trailing P/E of 1.7x is below its 10-year median of 2.9x.

    Total Valuation

    Enterprise value is 576.01% above the market cap, as debt exceeds cash.

    Market Cap$3.15B
    Enterprise Value$21.30B
    Latest price (Nov 17, 2026)$8.48

    Key Dates

    Last Earnings DateOct 28, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.13% in the quarter ended Sep 30, 2026 and grew 0.96% a year over 2 years.

    Shares Outstanding375.50M
    Shares Change (YoY)+1.13%
    Shares Change (QoQ)+0.13%
    Share Count Growth (2Y CAGR)+0.96%

    Valuation Ratios

    The price to sales ratio is 0.3x. Its year-end P/E ranged from 1.8x to 6.7x from 2016 to 2025.

    P/E Ratio1.7x
    Forward P/E1.6x
    P/S Ratio0.3x
    Forward P/S0.3x
    P/FCF Ratio1.7x
    P/OCF Ratio1.4x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 8.7x EBITDA and 11.4x free cash flow.

    EV / Sales1.9x
    EV / EBITDA8.7x
    EV / EBIT17.5x
    EV / FCF11.4x

    Price Statistics

    The stock is up 35.03% over 52 weeks and trades 27.52% above its 50-day average.

    Beta (1Y)0.98
    52-Week Change+35.03%
    1-Month Change+34.18%
    3-Month Change+23.08%
    6-Month Change+59.40%
    5-Year Change-70.80%
    10-Year Change-54.04%
    Total Return (1Y)+35.03%
    Total Return (3Y CAGR)+7.11%
    Total Return (5Y CAGR)-20.20%
    Return vs SPY (1Y)+25.66%
    Max Drawdown (1Y)-43.92%
    Max Drawdown (3Y)-59.28%
    Sharpe Ratio (1Y)0.54
    Correlation with SPY (1Y)0.23
    50-Day Average$6.65
    200-Day Average$5.82
    52-Week Range$4.33 to $9.04
    RSI (14 Days)67.6
    Average Volume (20 Days)4.93M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.56x current liabilities.

    Current Ratio1.56x
    Quick Ratio1.22x
    Debt / EBITDA8.46x
    Debt / FCF11.07x
    Interest Coverage0.75x

    Returns and Efficiency

    Return on invested capital is 6.30% over the last 12 months, against a 5-year average of 3.76%.

    Return on Assets (ROA)-3.25%
    Return on Invested Capital (ROIC)6.30%
    Return on Capital Employed (ROCE)5.87%
    ROA (5Y Average)-1.22%
    ROIC (5Y Average)3.76%
    Asset Turnover0.42x
    Inventory Turnover1.91x
    Receivables Turnover4.63x
    Cash Conversion Cycle204 days

    Scores

    BHC has an Altman Z-Score of 0.22, in the distress zone below 1.81, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score0.22
    Altman Z ZoneDistress
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $11.11B over the last 12 months is up 10.81% from the 12 months before.

    Revenue$11.11B
    Revenue Growth (YoY)+10.81%
    Gross Profit$8.07B
    Operating Income$1.25B
    Pretax Income-$353.00M
    Net Income-$828.00M
    EBITDA$2.44B
    EBIT$1.22B
    Reported EPS (TTM)$4.89

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$2.48B
    Total Debt$20.64B
    Net Debt$18.15B
    Net Debt Per Share$48.34
    Working Capital$2.66B
    Shareholder Equity-$1.33B
    Tangible Book Value-$15.07B
    Total Assets$25.48B
    Total Liabilities$25.82B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $344.00M of capital spending, operating cash flow left $1.86B of free cash flow.

    Operating Cash Flow$2.21B
    Capital Expenditures$344.00M
    Free Cash Flow$1.86B
    FCF Per Share$4.99
    Depreciation and Amortization$1.22B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 11.22%, against a 5-year average of 11.13%.

    Gross Margin72.62%
    Operating Margin11.22%
    Pretax Margin-3.18%
    Net Margin-7.45%
    EBITDA Margin21.96%
    EBIT Margin10.95%
    FCF Margin16.78%
    Gross Margin (5Y Average)71.01%
    Operating Margin (5Y Average)11.13%
    Net Margin (5Y Average)-4.06%

    Growth

    Revenue grew 8.11% a year over 3 years, and EPS 7.11% a year.

    Revenue Growth (3Y CAGR)+8.11%
    EPS Growth (3Y CAGR)+7.11%
    EPS Growth (5Y CAGR)-1.18%
    FCF Growth (5Y CAGR)+4.39%
    Operating Income Growth (3Y CAGR)+58.65%

    Revenue and profit by year

    Dividends and Yields

    BHC does not pay a dividend. Its free cash flow yield is 58.57%.

    Earnings Yield58.82%
    FCF Yield58.57%
    Shareholder Yield0.00%

    Peer Position

    Against 10 similar companies, BHC has the lowest P/E.

    P/E Ratio1.7x vs 11.8x median
    P/S Ratio0.3x vs 2.0x median
    ROIC6.30% vs 11.69% median
    Revenue Growth (Trailing 4 Quarters, YoY)+10.81% vs +13.23% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 3.30% and EPS growth at 7.43% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+3.30%
    EPS Growth Forecast (2Y CAGR)+7.43%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About BHC

    What is BHC's market cap?

    Bausch Health Companies has a market cap of $3.15B. Its enterprise value, which adds debt and subtracts cash, is $21.30B.

    What is BHC's P/E ratio?

    Bausch Health Companies has a trailing P/E ratio of 1.7x and a forward P/E of 1.6x.

    How many shares of BHC are outstanding?

    Bausch Health Companies has 375.50M shares outstanding. The count is up 1.13% from a year earlier.

    Does BHC pay a dividend?

    No. Bausch Health Companies does not pay a dividend.

    How much debt does BHC have?

    Bausch Health Companies has $20.64B of total debt and $2.48B of cash and equivalents, a net debt position of $18.15B.